Helene K Hansson

Title: Helene K Hansson: Innovator in Peptide Research

Introduction

Helene K Hansson is a notable inventor based in Malmö, Sweden. She has made significant contributions to the field of peptide research, particularly in relation to amyloid proteins. Her work has implications for understanding and potentially treating amyloid-related diseases.

Latest Patents

Hansson holds a patent for a peptide derived from amyloid A and its corresponding antiserum. The patent, which is characterized by substantially pure peptides containing amino acid residues from amyloid A protein and serum amyloid A protein, highlights the unique properties of these peptides. Specifically, the sum of the hydrophilicity values of the respective amino acid residues is greater than or equal to zero. This innovation opens new avenues for research and therapeutic applications.

Career Highlights

Helene K Hansson is associated with Gambro Lumdia AB, where she has been able to apply her expertise in peptide research. Her work has been instrumental in advancing the understanding of amyloid proteins and their role in various diseases.

Collaborations

Hansson has collaborated with notable colleagues, including Anders O Grubb and Lennart W Ljunggren. These partnerships have enriched her research and contributed to the development of innovative solutions in her field.

Conclusion

Helene K Hansson's contributions to peptide research, particularly her patented work on amyloid A, underscore her role as a leading innovator in the scientific community. Her ongoing research continues to pave the way for advancements in understanding amyloid-related conditions.